Explore By Subject Area   

Lead Editorial

Commercializing Therapies Requires Patient-Centricity and Advocacy

Commercializing Therapies Requires Patient-Centricity and Advocacy

To achieve good drug development and patient access, Biotech CMOs need to partner with and advocate for patients. Holly Schachner, MD, CMO, Deerfield Management, discusses how to work with patients from discovery through to commercialization, analyze the evolving therapeutic landscape and build a medical team to bring meaningful therapies forward.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.